Search all trials

Find therapies in clinical trials near you – page 11

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cardiac amyloidosis

Recruiting

Registered drugNo placebo

A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Acoramidis

Contact Research Centre

Pancreatic carcinoma metastatic+1

Recruiting

Registered drug

A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Allogenic stem cell transplantation

Recruiting

Registered drugNo placebo

Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years
Substances:Blinatumomab

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Endometrial cancer metastatic

Recruiting

Registered drugNo placebo

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Azd8205

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Prostate cancer

Recruiting

Registered drug

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Acute graft versus host disease in skin

Recruiting

Registered drugNo placebo

A study testing venetoclax for treating acute graft-versus-host disease in patients who received a stem cell transplant from a donor

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Venetoclax

Contact Research Centre

Astrocytoma malignant

Recruiting

Investigational

Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Vorasidenib

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drugNo placebo

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Find therapies in clinical trials near you – page 11

838 trials match your criteria

Cardiac amyloidosis

A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

Pancreatic carcinoma metastatic+1

A Study of BMS-986504 Combined with Nab-Paclitaxel and Gemcitabine for Patients with Untreated Metastatic Pancreatic Cancer with MTAP Gene Deletion

Allogenic stem cell transplantation

Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

Chronic obstructive pulmonary disease

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Endometrial cancer metastatic

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Non-small cell lung cancer+1

A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

Breast cancer+2

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Prostate cancer

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Prostate cancer

Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

Acute graft versus host disease in skin

A study testing venetoclax for treating acute graft-versus-host disease in patients who received a stem cell transplant from a donor

Astrocytoma malignant

Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

Renal cell carcinoma

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.